Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist (Q74510605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572624 AND SRC:MED&resulttype=core&format=json

11 November 2019

title

Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572624 AND SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

J. E. Moulder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9572624

20 December 2024

B. L. Fish

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9572624

20 December 2024

E. P. Cohen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9572624

20 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9572624

20 December 2024

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572624 AND SRC:MED&resulttype=core&format=json

11 November 2019

March 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9572624

full work available at URL

20 December 2024

https://api.elsevier.com/content/article/PII:S0167814097001758?httpAccept=text/xml

1 reference

10.1016/S0167-8140(97)00175-8

DOI

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

https://api.elsevier.com/content/article/PII:S0167814097001758?httpAccept=text/plain

20 December 2024

1 reference

10.1016/S0167-8140(97)00175-8

DOI

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

Radiotherapy and Oncology

20 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572624 AND SRC:MED&resulttype=core&format=json

11 November 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572624 AND SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572624 AND SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

307-315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572624 AND SRC:MED&resulttype=core&format=json

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Converting enzyme inhibition and progressive glomerulosclerosis in the rat

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Treatment of radiation nephropathy with captopril

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Successful brief captopril treatment in experimental radiation nephropathy

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Angiotensin receptor antagonists: focus on losartan

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Long-term enalapril and hydrochlorothiazide in radiation nephritis

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Influence of renal shielding on the incidence of late renal dysfunction associated with T-lymphocyte deplete bone marrow transplantation in adult patients COLLEEN

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

A computer program for comparing K samples with right-censored data

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists and calcium channel blocking agents: a review of potential benefits and possible adverse reactions

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Prophylaxis of bone marrow transplant nephropathy with captopril, an inhibitor of angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Late toxicity of total body irradiation with bone marrow transplantation in a rat model

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Angiotensin converting enzyme inhibitor captopril does not prevent acute gastrointestinal radiation damage in the rat

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Treatment of radiation nephropathy with ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathy

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Angiotensin II receptor antagonists in the prevention of radiation nephropathy

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Captopril inhibits proliferation of human lung fibroblasts in culture: a potential antifibrotic mechanism

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Radiation pneumotoxicity in rats: Modification by inhibitors of angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016/S0167-8140(97)00175-8

7 January 2021

10.1016/S0167-8140(97)00175-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572624 AND SRC:MED&resulttype=core&format=json

11 November 2019

1 reference